Mordechai Friedman is Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have made 1 open-market trade across 1 company since 2015, most recently 2015-12-14.
CIK 0001517390
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCLI | 5,000 | $6K |
Shares reported on the most recent Form 4, priced at the 2015-12-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCLI | SELL | 2015-12-14 | 2015-12-16 | $2.57 | $13K | -32.9% | -27.3% | -5.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.